On October 31, 2022, Helix BioPharma Corp. closed the transaction. The transaction included participation from directors and insiders for CAD 270,000 of the company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.24 CAD | +4.35% |
|
0.00% | +14.29% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+14.29% | 42.9M | |
+34.14% | 51.12B | |
-6.54% | 39.4B | |
+34.92% | 38.48B | |
+12.62% | 26.36B | |
-12.11% | 26.22B | |
-13.43% | 20.96B | |
+43.73% | 14.02B | |
+31.81% | 12.49B | |
-4.54% | 11.61B |
- Stock Market
- Equities
- HBP Stock
- News Helix BioPharma Corp.
- Helix BioPharma Corp. announced that it has received CAD 4.62902 million in funding